Results 181 to 190 of about 5,369,336 (287)

Harnessing skin-resident γδ T cells for immunotherapy in cutaneous squamous cell carcinoma. [PDF]

Sci Adv
Nasi G, Schöftner LC, Ronacher L, Sophianidis A, Feiser J, Aleksandrova T, Nussbaumer O, Hutton A, Zauner R, Moser-Waxenecker J, Varkhande SR, Sharma A, Ettinger M, Burner T, Laimer M, Guttmann-Gruber C, Gratz IK.   +16 more
europepmc   +1 more source

Management of Advanced Cutaneous Squamous Cell Carcinoma over the Last Decade: A Single-Centre Retrospective Study. [PDF]

Curr Oncol
Staeger R, Ehrat LG, Kamber N, Dummer R, Nägeli MC, Ramelyte E.   +5 more
europepmc   +1 more source

Robustness of a neural network approved for skin cancer diagnosis against variations in sequential images

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background: Convolutional neural networks (CNN) for skin cancer classification have shown results comparable to dermatologists but are vulnerable to minor image transformations. We investigated the robustness of a MDR class‐IIa certified CNN when classifying sequential images of identical lesions.
Alicia Zimmermann, Julia K. Winkler, Katharina Kommoss, Anastasia Vollmer, Ferdinand Toberer, Alexander Enk, Albert Rosenberger, Holger A. Haenssle   +7 more
wiley   +1 more source

Development of an immunocompetent cutaneous squamous cell carcinoma model identifies VISTA and CTLA-4 as targetable immune checkpoints. [PDF]

J Immunother Cancer
Rodriguez Rosario AE, Rangel R, Balbin N, Nizami ZN, Hadi J, Noor A, Dong L, Corona A, Bhavani N, Cruz Sanchez RM, Sunga GM, Veeramachaneni R, Manyam GC, Wang J, Yu W, Sikora AG, N Myers J, Rangel R.   +17 more
europepmc   +1 more source

A Review of Aryl Hydrocarbon Receptor-Mediated Immune Regulation in Cutaneous Squamous Cell Carcinoma Progression. [PDF]

Immunotargets Ther
Han H, Dong Q, Zhang Z, Li S, Zhang H, Wang X, Bai J, Shi L, Fu X, Zheng K, Liang L.   +10 more
europepmc   +1 more source

Real-World Response of Cemiplimab Immunotherapy for Treating Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma in a Tertiary UK Oncology Centre. [PDF]

J Skin Cancer
Umar S, Shahid Z, O'Cathail M, Sivanandan MA.   +3 more
europepmc   +1 more source

Facial Nerve Preservation in Advanced Facial Cutaneous Squamous Cell Carcinoma With Parotid Invasion: A Case Report. [PDF]

Cureus
Gonçalves CV, Priante AV, Da Cunha Bueno LG.   +2 more
europepmc   +1 more source

A guide to transcriptional cyclin‐dependent kinases in cancer

The FEBS Journal, EarlyView.
Transcriptional cyclin‐dependent‐kinases (tCDKs) facilitate gene expression by promoting RNA polymerase II (RNAPII) progression through discrete phases of the transcription cycle. Aberrant tCDK activity is detectable in different human cancers, thereby contributing to de‐regulated gene expression programs that drive oncogenic phenotypes.
Jennifer R. Devlin, Salla Kyheröinen, Ricky W. Johnstone   +2 more
wiley   +1 more source

Electrical resistance measurement in feline cutaneous squamous cell carcinoma treated with electrochemotherapy: a pilot study. [PDF]

Sci Rep
Franchini D, Ciccarelli S, Assumma C, Laino I, Di Bello A, D'Abramo C, Perrone C, Spugnini EP.   +7 more
europepmc   +1 more source

Merkel cell carcinoma: an updated guide for pathologists

Histopathology, EarlyView.
Merkel cell carcinoma (MCC) is an aggressive cutaneous neuroendocrine carcinoma for which the differential diagnosis can include other small cell malignancies (especially metastatic small cell carcinoma) or cutaneous carcinoma. Morphologic and immunophenotypic aberrancies in MCC can increase diagnostic challenge.
Paul W. Harms
wiley   +1 more source